Heart Failure: Presentation by Dr. Tooba Shahbaz
Heart Failure: Presentation by Dr. Tooba Shahbaz
Heart Failure: Presentation by Dr. Tooba Shahbaz
MYOCYTE LOSS:
• Leads to reduced ventricular contractility
• Post MI, chronic ischemia.
INAPPROPRIATE WORKLOAD:
• Ventricular outflow obstruction as in hypertension,
aortic stenosis, pulmonary hypertension, pulmonary
valve stenosis.
• Ventricular inflow obstruction as in mitral stenosis,
tricuspid stenosis.
• Ventricular volume overload as in aortic regurgitation,
ventricular septal defect, atrial septal defect.
• Arrhythmia as in atrial fibrillation, tachycardia,
cardiomyopathy, complete heart block.
RESTRICTED FILLING:
• Diastolic dysfunction as in constrictive pericarditis,
restrictive cardiomyopathy, left ventricular hypertrophy
and fibrosis, cardiac tamponade.
CLASSIFICATION OF CARDIAC
FAILURE
Systolic Dysfunction:
loop diuretics(furosemide, torsemide, bumetanide): Initial therapy
used to relieve the symptoms by ↓ preload. Does not reduce the
mortality. Note : not giving to asymptomatic patient
ACE inhibitors : initial therapy used to ↓ afterload by
vasodilatation and ↓ preload by absorption of the fluid and it
reduces the mortality.
Adverse effects → angioedema + cough Note: If patient
developed cough switch from ACEi to ARB. Note: If
patient developed hyperkalemia or renal impairment or
pregnant→ switch from ACEi to Hydralazine(arterial
dilator) with isosorbide dinitrate (Venodilator). Both
Hydralazine with isosorbide dinitrate and ARB reduce
the mortality
B-Blockers (metoprolol, bisoprolol, carvedilol) :anti-
ischemic , antiarrhythmic , decreased the heart rate
(decrease oxygen consumption increasing filling time)
& reduced remodeling of the heart → It decreases
mortality Note : The combination of B blockers and an
ACE inhibitors required for patient with LVEF less
than 40% either symptomatic or asymptomatic
spironolactone (potassium sparing diuretic that is used in
chronic CHF) : aldosterone antagonist, it reduces the
mortality. Note : if the patient developed gynecomastia,
impotence (cause its structurally similar to progesterone)
switch to eplerenone.
Digoxin : + inotropic effect used only relieve symptoms
with EF< 40% and it does not improve mortality.
The standard treatment for systolic cardiac failure is
diuretics + ACEin + B-blockers
The initial treatment for symptomatic patient is diuretics
+ vasodilation (ACEin, ARBs or hydralazine with
isosorbide)
When there is no benefit with medication devices are used and have been
shown to reduce mortality.
ICD (implantable cardiovascular defibrillator) indicated for patients
atleast 40 days post MI and EF <35%.
Cardiac resynchronization therapy: biventricular pacemaker has similar
indications as ICD except that these are used in prolonged QRS duration
>120msec.
Cardiac transplantation : last choice if the medication and devices can’t
control symptom
Diastolic Dysfunction:
The standard treatment for diastolic dysfunction is β blockers and
Diuretics
Digoxin and spironolactone should NOT be used.
ACE inhibitors and ARBs—benefit is not clear for diastolic dysfunction.
No medication have proven the mortality in diastolic dysfunction
Management of Acute decompensated Heart Failure (Acute Pulmonary edema)
A. Oxygen
B. loop diuretics (furosemide): most important drug that decreases the preload *Best initial
therapy
C. Nitrate (IV) : that decrease the afterload
D. Morphine can be used
Note : If pulmonary edema continuous despite these 4 so should add dobutamine (increased
contractility & decrease afterload)
Remember: - We don’t give β blockers in Acute cases (only in stable patient ).
- Digoxin (not used in acute settings, usually used if there was AFib ).
Contraindicated Medication on CHF
★ Metformin : may cause potentially fatal lactic acidosis.
★ Thiazolidinediones (glitazone): causes fluid retention.
★ NSAIDs : may increase risk of CHF exacerbation.
★ some of Calcium Channel blockers : may raise mortality.
THANK YOU!